Last Updated on January 20, 2024 by The Health Master
Amendments in NIPER
Amendments in NIPER: In a significant move to enhance the efficiency and dynamism of the National Institute of Pharmaceutical Education and Research (NIPER), the Department of Pharmaceuticals (DoP) has recently introduced crucial amendments to its statutes.
These revisions aim to facilitate the appointment of a director on a contractual basis with the prior approval of the visitor.
Here’s a comprehensive look at the key changes and their implications for the institute’s leadership.
Statute 9: A Transformational Shift
Previously, Statute 9 governed the tenure and reappointment of the director.
It stated that the appointment would be for a five-year term, extendable for an additional five years, provided the upper age limit did not exceed 70 years.
However, the recent amendment in NIPER, effective from the date of its official gazette publication, has ushered in a new era.
The revised statute now empowers the National Institute of Pharmaceutical Education and Research Council, with the prior approval of the visitor, to appoint a director on a contractual basis.
This contract spans a period of up to five years, with the possibility of renewal for an additional five-year term, ensuring the upper-age limit remains within seventy years.
Crucial Terms and Conditions
The amendment introduces a comprehensive schedule outlining the terms and conditions of the contract. According to this schedule:
- The appointee assumes the vital roles of principal academic and executive officer of the institute. They serve as the full-time director with powers and responsibilities as defined by the Act.
- The appointee dedicates their entire professional focus to the institute, adhering to the Conduct Rules and other provisions of the Act.
- Information acquired during the appointee’s tenure is to be treated with the utmost confidentiality, in accordance with the Indian Officials Secrets Act, 1923 (19 of 1923), and any subsequent amendments.
Flexibility in Termination
The contract with the director is designed to offer flexibility to both parties. The institute reserves the right to terminate the contract with a three-month notice period. Conversely, the director also has the option to terminate their service by providing a three-month written notice to the institute.
Academic Involvement
In an encouraging development, the director, while holding this prestigious position, is accorded the status of professor in their respective department. This enables them to actively engage in teaching and research within the department, subject to their convenience and availability.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Pharma GMP Audit and Self Inspection course begins at NIPER
NIPER gets patent for its invention for new anti-TB compound
NIPER (Amendment) Act, 2021 comes into force
USFDA issues Form 483 with one observation to Aurobindo: Andhra Pradesh
USFDA issues warning letter to Fresenius Kabi: Read detail
Amendment in D&C Act: Decriminalizing Offences for Trust-Based Governance
USFDA gives positive Inspection Report to Lupin: Nagpur
Drug recall: Ibrexafungerp tablets recalled due to cross contamination
USFDA’s New Inspection Approach for India’s Pharmaceutical Industry
Regulatory Practices: Gujarat FDCA Collaborates with USFDA for Strengthening
GMP Compliance for MSME Pharma Companies: Challenges and Perspectives
Govt issues draft notification for inclusion of Oseltamivir and Zanamivir in Schedule H1
Empowering Teens: New Contraceptive Implant to Combat Teenage Pregnancy
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: